Catalyst Pharmaceuticals
CPRX
$14.89
Share price
1.43%
Change (1 day)
-5.52%
Change (1 year)
Categories
Catalyst Pharmaceuticals (CPRX) - Total assets
Total assets on the balance sheet as of December 2023 : $0.47 B
According to Catalyst Pharmaceuticals's latest financial reports the company's total assets are $0.47 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Catalyst Pharmaceuticals - Total assets on balance sheet (from 2004 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.47 B | 25.15% |
| 2022-12-31 | $0.37 B | 57.97% |
| 2021-12-31 | $0.23 B | 23.62% |
| 2020-12-31 | $0.19 B | 71.17% |
| 2019-12-31 | $0.11 B | 85.9% |
| 2018-12-31 | $60.44 M | -29.21% |
| 2017-12-31 | $85.38 M | 104.73% |
| 2016-12-31 | $41.7 M | -30.61% |
| 2015-12-31 | $60.1 M | 36.88% |
| 2014-12-31 | $43.9 M | 73.07% |
| 2013-12-31 | $25.36 M | 51.11% |
| 2012-12-31 | $16.78 M | 168.66% |
| 2011-12-31 | $6.24 M | 7.16% |
| 2010-12-31 | $5.83 M | -26.8% |
| 2009-12-31 | $7.96 M | -33.8% |
| 2008-12-31 | $12.03 M | -27.86% |
| 2007-12-31 | $16.67 M | -19.11% |
| 2006-12-31 | $20.61 M | 2511.88% |
| 2005-12-31 | $0.78 M | 325.86% |
| 2004-12-31 | $0.18 M | |
| 2002-12-31 | $0.11 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 35,541.99% | 🇺🇸 USA |
 Pfizer PFE | $226.50 B | 48,080.02% | 🇺🇸 USA |
 Abbott Laboratories ABT | $73.21 B | 15,473.67% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $3.26 B | 594.42% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.36 B | -22.07% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $6.84 B | 1,355.31% | 🇺🇸 USA |